Applied Filters
Biogen blocking bid rejected; signs $2.4bn deal
The US Court of Appeals for the Federal Circuit has rejected Biogen’s bid to block a generic version of its multiple sclerosis drug, pending an appeal against a lower court’s ruling.
University of California gains ground after EPO backs CRISPR patent
In a victory for the University of California, the European Patent Office has affirmed a CRISPR patent issued to Emmanuelle Charpentier, the University of California, and the University of Vienna.
Broad Institute presses for CRISPR settlement after EPO revocation
A competitor of the Broad Institute has said that a European Patent Office ruling last week has weakened the CRISPR/Cas9 patent owner’s negotiating hand in any future settlement between the parties.
Illumina escapes genetics trade secrets claims
A US judge has thrown out a lawsuit accusing US biotechnology companies Illumina and Affymetrix of a “complex, multi-decade concerted effort” to conceal the theft of trade secrets in the 1990s.
Breaking: EPO revokes Broad’s CRISPR patent
In a dramatic reversal, a European Patent Office’s board of appeal has upheld the revocation of a Broad Institute CRISPR/Cas9 patent.
Breaking: EPO board to refer key issues in Broad appeal to higher panel
The European Patent Office intends to refer questions in the Broad Institute’s ongoing CRISPR patent case to the enlarged board of appeal, meaning the case is set to drag out further.
EPO appeals board weighs-up Broad’s CRISPR claims
The first day of a landmark hearing on CRISPR ownership dealt nearly exclusively with untangling linguistic arguments, lawyers following the proceedings told LSIPR.
Illumina and Pacific Biosciences terminate $1.2bn deal
Gene-sequencing companies Illumina and Pacific Biosciences have “mutually agreed” to terminate their $1.2 million merger agreement, under which Illumina would have acquired PacBio.
USPTO grants University of California 20th CRISPR patent
The US Patent and Trademark Office has granted the University of California its 20th US patent on CRISPR-Cas9 gene-editing technologies.
Fed Circuit says warning labels could be protectable by copyright
Syngenta will be allowed to raise claims that Willowood infringed its copyright by copying warning labels on pesticides, the US Court of Appeals for the Federal Circuit ruled yesterday, December 18.
